3.54
3.01%
-0.11
After Hours:
3.65
0.11
+3.11%
Aileron Therapeutics Inc stock is traded at $3.54, with a volume of 87,367.
It is down -3.01% in the last 24 hours and up +40.48% over the past month.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
See More
Previous Close:
$3.65
Open:
$3.6
24h Volume:
87,367
Relative Volume:
1.21
Market Cap:
$74.96M
Revenue:
-
Net Income/Loss:
$-12.94M
P/E Ratio:
-1.2465
EPS:
-2.84
Net Cash Flow:
$-13.83M
1W Performance:
-4.58%
1M Performance:
+40.48%
6M Performance:
-46.61%
1Y Performance:
+132.89%
Aileron Therapeutics Inc Stock (ALRN) Company Profile
Name
Aileron Therapeutics Inc
Sector
Industry
Phone
(737) 802-1989
Address
12407 N. MOPAC EXPY., AUSTIN, MA
Aileron Therapeutics Inc Stock (ALRN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-24-17 | Initiated | BofA/Merrill | Buy |
Jul-24-17 | Initiated | Jefferies | Buy |
Jul-24-17 | Initiated | William Blair | Outperform |
Aileron Therapeutics Inc Stock (ALRN) Latest News
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 13.4% in September - MarketBeat
Alumis (NASDAQ:ALMS) Trading 4.8% Higher - MarketBeat
Keeping an Eye on Alx Oncology Holdings Inc (ALXO) After Insider Trading Activity - Knox Daily
Ready to Jump After Recent Trade: Alx Oncology Holdings Inc (ALXO) - SETE News
ALXO stock touches 52-week low at $1.87 amid market challenges - Investing.com
Alumis (NASDAQ:ALMS) Shares Gap Down to $11.86 - MarketBeat
Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex
What is the investor’s view on Alx Oncology Holdings Inc (ALXO)? - US Post News
Insider Sale Alert: Aldeyra Therapeutics Inc [ALDX] – Is it Time to sell? - Knox Daily
Alector (NASDAQ:ALEC) Shares Down 5.6% - MarketBeat
Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World
Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) - Nasdaq
Market Update: Alx Oncology Holdings Inc (ALXO) Sees Negative Movement, Closing at 2.07 - The Dwinnex
Keith Johns Joins Allurion's Board Of Directors - MPO-mag
HighVista Strategies LLC Makes New Investment in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Defense World
Taking on analysts’ expectations and winning: Alumis Inc. (ALMS) - SETE News
Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) - StockTitan
Healius sells Lumus imaging unit to Affinity for USD 657M - Medical Buyer
Australia Medical Diagnostics Firm Healius Sells Lumus to Affinity for $657 Million - BNN Bloomberg
Renaissance Technologies LLC Sells 800 Shares of Alexander’s, Inc. (NYSE:ALX) - Defense World
Alector (NASDAQ:ALEC) Stock Price Up 9% - Defense World
1,959,896 Shares in Alumis Inc. (NASDAQ:ALMS) Bought by SR One Capital Management LP - MarketBeat
Aileron Therapeutics Inc Inc. (ALRN) Price Performance: The Role of Supply and Demand - The InvestChronicle
Closing Bell Recap: Aileron Therapeutics Inc (ALRN) Ends at 2.91, Reflecting a 9.81 Upturn - The Dwinnex
Alector (NASDAQ:ALEC) Stock Price Up 9% - MarketBeat
Altair Engineering: Rating Downgrade As Near-Term Upside Is Limited (NASDAQ:ALTR) - Seeking Alpha
Alumis (NASDAQ:ALMS) Shares Down 2.6% - MarketBeat
Alesi Surgical wins FDA clearance for smoke management device and lands new funding - Mass Device
Alector, Inc. (NASDAQ:ALEC) Short Interest Down 5.7% in August - Defense World
Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World
Australia's ALS tumbles on subdued half-year forecast - XM
Market cap of Allarity Therapeutics Inc [ALLR] reaches 4.22M – now what? - The DBT News
Alumis (NASDAQ:ALMS) Stock Price Up 5.3% - Defense World
Alexander's (NYSE:ALX) Hits New 52-Week High at $248.10 - MarketBeat
In the Green: Alector Inc (ALEC) Closes at 5.64, Up/Down -0.70 from Previous Day - The Dwinnex
Athira shifts focus to ALS drug after Alzheimer’s flop - The Pharma Letter
Is Alector Inc (ALEC) worth investing in despite its undervalued state? - US Post News
Alector (NASDAQ:ALEC) Receives Overweight Rating from Cantor Fitzgerald - Defense World
Alimera Sciences completes merger with ANI Pharmaceuticals - Investing.com India
Altius Minerals (TSE:ALS) Price Target Raised to C$29.00 at Canaccord Genuity Group - Defense World
Guggenheim raises PT on ANI Pharma after Alimera deal completion - XM
Alumis (NASDAQ:ALMS) Reaches New 12-Month Low at $10.37 - MarketBeat
Prepare Yourself for Liftoff: Alector Inc (ALEC) - SETE News
ANI Pharmaceuticals completes acquisition of Alimera Sciences - TipRanks
ANI Pharmaceuticals completes purchase of Alimera Sciences (NASDAQ:ALIM) - Seeking Alpha
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences - GlobeNewswire
ANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences - TipRanks
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences - GlobeNewswire
(ALEC) Trading Advice - Stock Traders Daily
Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study - Zacks Investment Research
University of Texas Texas AM Investment Management Co. Makes New Investment in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - MarketBeat
Aileron Therapeutics Inc Stock (ALRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):